Evidence map›Paper›PMID 36339401›Full record

ArticleFrontiers in endocrinology2022

High levels of oxidized fatty acids in HDL impair the antioxidant function of HDL in patients with diabetes.

Juan Feng, Yunfeng Wang, Weixi Li, Yue Zhao, Yi Liu, Xingang Yao, Shuwen Liu, Ping Yu, Rongsong Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. ANGPTL3 is a novel HDL component that regulates HDL function.Journal of translational medicine · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Juan FengCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen Guangdong, China.
Yunfeng WangDepartment of Endocrinology, Shenzhen Sami Medical Center (The Fourth People's Hospital of Shenzhen), Shenzhen Guangdong, China.
Weixi LiCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen Guangdong, China.
Yue ZhaoClinical Laboratory, Shenzhen Sami Medical Center (The Fourth People's Hospital of Shenzhen), Shenzhen Guangdong, China.
Yi LiuClinical Laboratory, Shenzhen Sami Medical Center (The Fourth People's Hospital of Shenzhen), Shenzhen Guangdong, China.
Xingang YaoNational Medical Products Administration Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou Guangdong, China.
Shuwen LiuNational Medical Products Administration Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou Guangdong, China.
Ping YuDepartment of Endocrinology, Shenzhen Sami Medical Center (The Fourth People's Hospital of Shenzhen), Shenzhen Guangdong, China.
Rongsong LiCollege of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen Guangdong, China.
Shenzhen Technology University · CNFourth People's Hospital of Shenzhen · CNThe Fourth People's Hospital · CNNational Medical Products Administration · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Previous studies demonstrate that the antioxidant functions of high-density lipoprotein (HDL) are impaired in diabetic patients. The composition of HDL plays an important role in maintaining the normal functionality of HDL. In this study, we compared the levels of oxidized fatty acids in HDL from diabetic subjects and non-diabetic healthy controls, aiming to investigate the role of oxidized fatty acids in the antioxidant property of HDL. Methods: HDL was isolated from healthy subjects (n=6) and patients with diabetes (n=6, hemoglobin A1c ≥ 9%, fasting glucose ≥ 7 mmol/L) using a dextran sulfate precipitation method. Cholesterol efflux capacity mediated by HDL was measured on THP-1 derived macrophages. The antioxidant capacity of HDL was evaluated with dichlorofluorescein-based cellular assay in human aortic endothelial cells. Oxidized fatty acids in HDL were determined by liquid chromatography-tandem mass spectrometry. The correlations between the levels of oxidized fatty acids in HDL and the endothelial oxidant index in cells treated with HDLs were analyzed through Pearson's correlation analyses, and the effects of oxidized fatty acids on the antioxidant function of HDL were verified Results: The cholesterol efflux capacity of HDL and the circulating HDL-cholesterol were similar in diabetic patients and healthy controls, whereas the antioxidant capacity of HDL was significantly decreased in diabetic patients. There were higher levels of oxidized fatty acids in HDL isolated from diabetic patients, which were strongly positively correlated with the oxidant index of cells treated with HDLs. The addition of a mixture of oxidized fatty acids significantly disturbed the antioxidant activity of HDL from healthy controls, while the apolipoprotein A-I mimetic peptide D-4F could restore the antioxidant function of HDL from diabetic patients. Conclusion: HDL from diabetic patients displayed substantially impaired antioxidant activity compared to HDL from healthy subjects, which is highly correlated with the increased oxidized fatty acids levels in HDL.

Indexed as

Diabetes MellitusLipoproteins, HDLAntioxidantsCholesterol, HDLEndothelial CellsFatty AcidsHumansOxidantsAntioxidantsCholesterol, HDLFatty AcidsLipoproteins, HDLOxidantsantioxidant activitycardiovascular diseasediabeteshigh-density lipoproteinoxidized fatty acids

Identifiers

PMID36339401
PMCPMC9630736
OpenAlexW4306930554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.